|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 10/29/14 Amgen Inc 10-Q 9/30/14 77:13M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 751K
2: EX-10.18 Agreement Between Amgen Inc. and Mr. David W. HTML 87K
Meline
3: EX-31 Rule 13A-14(A) Certifications HTML 36K
4: EX-32 Section 1350 Certifications HTML 25K
51: R1 Document and Entity Information HTML 40K
40: R2 Condensed Consolidated Statements of Income HTML 86K
(Unaudited)
49: R3 Condensed Consolidated Statements of Comprehensive HTML 47K
Income (Unaudited)
54: R4 Condensed Consolidated Balance Sheets (Unaudited) HTML 100K
71: R5 Condensed Consolidated Balance Sheets (Unaudited) HTML 29K
(Parenthetical)
42: R6 Condensed Consolidated Statements of Cash Flows HTML 112K
(Unaudited)
48: R7 Summary of significant accounting policies HTML 35K
36: R8 Restructuring HTML 64K
26: R9 Business combinations HTML 58K
72: R10 Income taxes HTML 33K
56: R11 Earnings per share HTML 55K
55: R12 Available-for-sale investments HTML 225K
61: R13 Inventories HTML 31K
62: R14 Goodwill and other intangible assets HTML 87K
59: R15 Financing arrangements HTML 76K
63: R16 Stockholders' equity HTML 148K
50: R17 Fair value measurement HTML 224K
53: R18 Derivative instruments HTML 172K
58: R19 Contingencies and commitments HTML 34K
77: R20 Summary of significant accounting policies HTML 52K
(Policies)
67: R21 Restructuring (Tables) HTML 62K
45: R22 Business combinations (Tables) HTML 46K
57: R23 Earnings per share (Tables) HTML 52K
47: R24 Available-for-sale investments (Tables) HTML 225K
19: R25 Inventories (Tables) HTML 30K
68: R26 Goodwill and other intangible assets (Tables) HTML 76K
74: R27 Financing arrangements (Tables) HTML 75K
31: R28 Stockholders' equity (Tables) HTML 140K
30: R29 Fair value measurement (Tables) HTML 200K
34: R30 Derivative instruments (Tables) HTML 156K
35: R31 Summary of significant accounting policies HTML 25K
(Details)
37: R32 Restructuring (Details Textual) HTML 35K
17: R33 Restructuring (Details) HTML 40K
65: R34 Restructuring (Details 1) HTML 32K
44: R35 Business combinations (Details) HTML 27K
46: R36 Business combinations (Details 1) HTML 60K
22: R37 Business combinations (Details 2) HTML 27K
76: R38 Business combinations (Details Textual) HTML 57K
11: R39 Income taxes (Details) HTML 37K
38: R40 Earnings per share (Details) HTML 44K
70: R41 Available-for-sale investments (Details) HTML 56K
21: R42 Available-for-sale investments (Details 1) HTML 39K
29: R43 Available-for-sale investments (Details 2) HTML 42K
33: R44 Available-for-sale investments Available-for-sale HTML 52K
investments (Details 3)
41: R45 Available-for-sale investments (Details Textual) HTML 33K
16: R46 Inventories (Details) HTML 33K
25: R47 Goodwill and other intangible assets (Details) HTML 29K
13: R48 Goodwill and other intangible assets (Details 1) HTML 46K
69: R49 Goodwill and other intangible assets (Details HTML 45K
Textual)
20: R50 Financing arrangements (Details) HTML 116K
66: R51 Stockholders' equity (Details Textual) HTML 33K
23: R52 Stockholders' equity (Details 1) HTML 86K
39: R53 Stockholders' equity (Details 2) HTML 45K
12: R54 Fair value measurement (Details) HTML 140K
15: R55 Fair value measurement Fair value measurement HTML 28K
(Details 1)
32: R56 Fair value measurements (Details Textual) HTML 50K
18: R57 Derivative instruments (Details) HTML 27K
73: R58 Derivative instruments (Details 1) HTML 27K
43: R59 Derivative instruments (Details 2) HTML 39K
60: R60 Derivative instruments (Details 3) HTML 25K
24: R61 Derivative instruments (Details 4) HTML 41K
27: R62 Derivative instruments (Details Textual) HTML 49K
64: R63 Contingencies and commitments (Details) HTML 22K
75: XML IDEA XML File -- Filing Summary XML 113K
14: EXCEL IDEA Workbook of Financial Reports XLSX 257K
28: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 2.31M
5: EX-101.INS XBRL Instance -- amgn-20140930 XML 3.59M
7: EX-101.CAL XBRL Calculations -- amgn-20140930_cal XML 234K
8: EX-101.DEF XBRL Definitions -- amgn-20140930_def XML 665K
9: EX-101.LAB XBRL Labels -- amgn-20140930_lab XML 1.62M
10: EX-101.PRE XBRL Presentations -- amgn-20140930_pre XML 969K
6: EX-101.SCH XBRL Schema -- amgn-20140930 XSD 183K
52: ZIP XBRL Zipped Folder -- 0000318154-14-000022-xbrl Zip 262K
| AMGN-EX31_2014.9.30-Q3 |
1. | I have reviewed this Quarterly Report on Form 10-Q of Amgen Inc.; |
2. | Based on my knowledge, this quarterly report does not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. | The
registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and |
(d) | Disclosed in this quarterly report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent
functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the
registrant’s internal control over financial reporting. |
Date: October 29, 2014 | |
Chairman of the Board, | |
Chief
Executive Officer and President | |
1. | I have reviewed this Quarterly Report on Form 10-Q of Amgen Inc.; |
2. | Based
on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
4. | The
registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and |
(d) | Disclosed in this quarterly report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent
functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the
registrant’s internal control over financial reporting. |
Date: October 29, 2014 | /s/ DAVID W. MELINE |
Executive Vice President and Chief Financial Officer | |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/29/14 | 4 | ||
| For Period end: | 9/30/14 | |||
| List all Filings | ||||